LOCALY ADVANCED NON-SMALL CELL LUNG CANCER TREATMENT

  • Neringa Vagulienė
DOI: https://doi.org/10.37499/PIA.144
Keywords: lung cancer, immunotherapy, chemoradiotherapy, durvalumab

Abstract

Lung cancer is the most common cancer worldwide, with 1,8 million new cases in 2012. The treatment recommendations for non-small cell lung cancer depend on correctly identifying stage. Immunotherapy is an existing area of cancer research and treatment, which is showing promising results for peoplewith advanced lung cancers but very little progress has been made in the treatment of stage III lung cancer.

Author Biography

Neringa Vagulienė

Department of Pulmonology, Medical Academy, Lithuanian University of Health Sciences 

How to Cite
1.
Vagulienė N. LOCALY ADVANCED NON-SMALL CELL LUNG CANCER TREATMENT [Internet]. PIA 2019 May;3(1):37-40.[cited 2024 May 19 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/144
Issue
Vol 3 No 1 (2019): Pulmonology and Allergology
Section
Pulmonology and allergology